Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, RSV Vaccines
Leads the global real-world evidence and health outcomes research strategy for RSV vaccines, serving as the single accountable point for data generation plans across in-market and pre-launch assets. Oversees study design, execution, translation and dissemination while engaging HTA agencies, guideline groups and payer stakeholders to support access and value-based pricing. Combines line management of analytic staff with cross-functional leadership across clinical, commercial and market access teams.